AIHealthcare

AI-in-Healthcare Intelligence Platform

ConcertAI

Healthcare AI Oncology-focused generative and agentic AI, real-world data, clinical development, and clinical-tria Series C

ConcertAI is a privately held healthcare and life-sciences AI company providing predictive, generative, and agentic AI SaaS products alongside real-world, clinico-genomic and multimodal data solutions. Its principal focus is oncology, with offerings intended to support clinical development, clinical-trial optimization, research, and advanced oncology insights. The company characterizes its market position as a leader in oncology-focused generative and agentic AI SaaS and healthcare/life-sciences real-world data solutions. In a January 2024 company release, it described its oncology and hematology real-world-data asset as the largest multimodal dataset of its kind; this is a company claim, not independently verified here.

Company Details

Website
concertai.com
Headquarters
Cambridge, Massachusetts, United States
Founded
2018
Funding
More than $230M through Series C (company-reported, January 2025). Third-party company databases rep

Subscriber Intelligence

  • • Deal signal alerts for this company
  • • Sentiment & risk scoring
  • • Competitive framework analysis
  • • Regulatory event monitoring
← Back to Company Directory